BUSULFAN vs EVDI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. BUSULFAN and EVDI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BUSULFAN	EVDI
Rating	72/100	66/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BUSULFAN	TRABECTEDIN
Manufacturer	Actavis	Apotex
Dosage forms	Injectable, Solution	Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	None	None
Treats	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis	Leiomyosarcoma, Liposarcoma

busulfan evdi

Rating

72/100

66/100

Pharmacy pays

—

Type

Active ingredient

BUSULFAN

TRABECTEDIN

Manufacturer

Actavis

Apotex

Dosage forms

Injectable, Solution

Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Leiomyosarcoma, Liposarcoma

Frequently asked questions

Which is better-rated, Busulfan or Evdi?

By our independent rating, Busulfan scores higher — 3.6 vs 3.3 out of 5 for Evdi. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Busulfan and Evdi?

Busulfan contains Busulfan, while Evdi contains Trabectedin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.